- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.
Trade-Ideas LLC identified C.R. Bard (BCR) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate